Efficacy and safety of sofosbuvir plus simeprevir in patients with advanced HCV cirrhosis

被引：0
|
作者：
Capraru, Camelia I. [1 ]
Kuczynski, Magdalena [1 ]
La, Danie [1 ]
Kaznowski, Diana [1 ]
Kowgier, Matthew [1 ]
Wong, David K. [1 ]
Juan, Joshua [1 ]
Shah, Hemant [1 ]
Ramji, Alnoor [2 ]
Janssen, Harry L. [1 ]
Feld, Jordan J. [1 ]
机构：
[1] Toronto Western Hosp, Univ Hlth Network, Liver Clin, Toronto, ON M5T 2S8, Canada
[2] Gastrointestinal Res Inst, Vancouver, BC, Canada
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
963
引用
收藏
页码：665A / 665A
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of Simeprevir plus Sofosobuvir with or without Ribavirin in Patients with Decompensated Genotype 1 Hepatitis C induced Cirrhosis
    Modi, Apurva A.
    Nazario, Hector
    Gonzalez, Stevan A.
    Gautam, Manjushree
    Weinstein, Jeffrey S.
    Mantry, Parvez S.
    Barnes, Maisha
    Habib, Adil
    McAfee, Jean L.
    Teachenor, Olga
    Tujague, Lauren
    Trotter, James F.
    [J]. HEPATOLOGY, 2014, 60 : 661A - 661A
  • [32] Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease
    Ram, Bhamidimarri Kalyan
    Frank, Czul
    Adam, Peyton
    Cynthia, Levy
    Maria, Hernandez
    Lennox, Jeffers
    David, Roth
    Eugene, Schiff
    Christopher, O'Brien
    Paul, Martin
    [J]. JOURNAL OF HEPATOLOGY, 2015, 63 (03) : 763 - 765
  • [33] Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study
    Pellicelli, Adriano M.
    Palitti, Valeria Pace
    Vignally, Pascal
    Ceccherini-Silberstein, Francesca
    Siciliano, Massimo
    Giannelli, Valerio
    Moretti, Alessandra
    Tarquini, Pierluigi
    Scifo, Gaetano
    Messina, Vincenzo
    Ascione, Antonio
    Izzi, Antonio
    Marignani, Massimo
    D'Ambrosio, Cecilia
    Fondacaro, Lucia
    Ettorre, Giuseppe M.
    Ialongo, Pasquale
    Sacco, Rodolfo
    Perno, Carlo F.
    Barbarini, Giorgio
    [J]. LIVER INTERNATIONAL, 2017, 37 (05) : 653 - 661
  • [34] Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
    Flamm, Steven
    Lawitz, Eric
    Borg, Brian
    Charlton, Michael
    Landis, Charles
    Reddy, K. Rajender
    Shiffman, Mitchell
    Alsina, Angel
    Chang, Charissa
    Ravendhran, Natarajan
    Hernandez, Candido
    Hezode, Christophe
    Scherbakovsky, Stacey
    Mercier, Renee-Claude
    Samuel, Didier
    [J]. VIRUSES-BASEL, 2023, 15 (10):
  • [35] Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis
    Rao, Huiying
    Song, Guangjun
    Li, Guangming
    Yang, Yongfeng
    Wu, Xiaofeng
    Guan, Yujuan
    Mao, Qing
    Jiang, Xiangjun
    Wang, Changyuan
    Zhang, Ying
    Jia, Jidong
    Guo, Xiaolin
    Li, Chenghao
    Ning, Jing
    Qin, Hong
    Pan, Hai
    Wei, Lai
    [J]. JOURNAL OF VIRAL HEPATITIS, 2020, 27 (01) : 45 - 51
  • [36] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E877 - E882
  • [37] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E877 - E882
  • [38] Response to Real life Egyptian experience ofefficacy / safety of Simeprevir\ Sofosbuvir in HCV genotypeIV
    Eletreby, Rasha
    Elakel, Wafaa
    El Raziky, Maissa
    Esmat, Gamal
    [J]. LIVER INTERNATIONAL, 2017, 37 (05) : 766 - 766
  • [39] Improvement in liver disease parameters following treatment with daclatasvir plus sofosbuvir and ribavirin in patients with chronic HCV infection and advanced cirrhosis
    Fontana, Robert J.
    Poordad, Fred
    Schiff, Eugene R.
    Vierling, John M.
    Landis, Charles S.
    Bhore, Rafia
    Yin, Philip
    Noviello, Stephanie
    Swenson, Eugene S.
    [J]. HEPATOLOGY, 2015, 62 : 558A - 559A
  • [40] Sofosbuvir in combination with simeprevir plus /- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium
    Moreno, Christophe
    Lasser, Luc
    Delwaide, Jean
    Starkel, Peter
    Laleman, Wim
    Langlet, Philippe
    Reynaert, Hendrik
    Bourgeois, Stefan
    Dastis, Sergio Negrin
    Gustot, Thierry
    Francque, Sven M.
    Geerts, Anja M.
    Van Steenkiste, Christophe
    de Galocsy, Chantal
    Assene, Collins
    Orlent, Hans
    Nkuize, Marcel
    Degre, Delphine
    [J]. HEPATOLOGY, 2015, 62 : 746A - 746A
12345